Dated: September 8, 2004 Contact: Jonathan W. Emord Emord & Associates, P.C. (202-466-6937) Washington, D.C. – Today the Food and Drug Administration (FDA) authorized a qualified health claim linking consumption of omega-3 fatty acids with a reduced risk of coronary heart disease (CHD): “Supportive but not conclusive research shows that consumption of EPA and DHA […]
HON. RON PAUL OF TEXAS BEFORE THE US HOUSE OF REPRESENTATIVES November 10, 2005 Free Speech and Dietary Supplements Mr. Speaker, I rise to introduce the Health Freedom Protection Act. This bill restores the First Amendment rights of consumers to receive truthful information regarding the benefits of foods and dietary supplements by codifying the First
11808 WOLF RUN LANE CLIFTON, VA 20124 4140 E. BASELINE ROAD SUITE 201 MESA, AZ 85206 1050 SEVENTEENTH STREET, N.W. SUITE 600 WASHINGTON, D.C. 20036 (202) 466-6937 * FAX (202) 466-6938 WWW.EMORD.COM Washington, D.C. – Emord & Associates is pleased to announce a partial settlement with FDA following the decision of the U.S. District Court
FDA Agrees to Allow Selenium Qualified Health Claims with Succinct Disclaimers Read Post »
FDA Censorship: Freedom on Trial It may come as a surprise to you, but the federal Food and Drug Administration prohibits makers of foods and dietary ingredients from informing you of the effects those substances have on disease. Most of us know that water treats dehydration and that prune juice treats chronic constipation, but if
Legal Resume as of December 10, 2012 Please find below a list of matters before the Food and Drug Administration (FDA) in which Youngevity (formerly American Longevity) participated. The pending nature or resolution of each issue is noted. Matters are in reverse chronological order with the currently active matters in each category listed first. Litigation:
